Skip to Content

PGIM Target Date 2025 R1 PDEDX Fund Analysis

| Medalist Rating as of | See PGIM Investment Hub

Morningstar’s Analysis PDEDX

Will PDEDX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

PGIM Target Date 2025 R1's recent fee cut underpins an upgrade to this strategy's Morningstar Medalist Rating to Neutral from Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor